J Biol Chem, Vol. 274, Issue 37, 26057-26064, September 10, 1999
Substrate- and Inhibitor-induced Conformational Changes in the
Yeast V-ATPase Provide Evidence for Communication between the
Catalytic and Proton-translocating Sectors*
Carolina
Landolt-Marticorena
,
Walter H.
Kahr
,
Paul
Zawarinski
,
Judy
Correa
, and
Morris F.
Manolson
§¶
From the
Hospital for Sick Children, Toronto,
Ontario, M5G 1X8, Canada and § Faculty of Dentistry,
University of Toronto, Toronto, Ontario, M5G 1G6, Canada
 |
ABSTRACT |
The vacuolar-type
H+-ATPases (V-ATPases) are composed of two distinct
sectors, a catalytic complex (V1) involved in ATP
hydrolysis and a membrane-associated complex (V0) mediating
proton translocation across a lipid bilayer. To date, little is known
about the mechanism by which these two functions are coupled. We sought
to examine the impact of nucleotide and cation binding on the structure
of the core components of the catalytic complex and to determine whether conformational changes within the catalytic complex impact subunits of the membrane-associated complex. Nucleotide- and cation- induced changes in the catalytic core of the V-ATPase were investigated by monitoring changes in the rate and pattern of tryptic digests. ATP·Mg-induced changes were detected in both the catalytic (Vma1p or
69 kDa) and the regulatory subunits (Vma2p or 60 kDa) of the V1 sector. ATP alone increased the rate of trypsinization
of the regulatory subunit, but did not have any effect on Vma1p.
Surprisingly, ATP also had an impact on the 95-kDa subunit, a component
of the V0 sector of the V-ATPase. Although the presence of
divalent cations had no impact on the V1 sector, the rate
of trypsinization of the 95-kDa subunit was greatly enhanced. The
effect of divalent cations on the structure of the 95-kDa subunit was
abrogated when trypsinization was performed in the absence of the
catalytic sector. Addition of bafilomycin A1, a V-ATPase
inhibitor that putatively binds to the 95-kDa subunit, increased the
rate of trypsinization of the catalytic subunit. These data suggest
that structural alterations within the V1 sector result in
alterations within the V0 sector and vice
versa. Clearly, a structural link must exist to couple the two
sectors. The 95-kDa subunit is ideally suited to fulfill this role.
Hydropathy analysis suggests a bipartite structure, with the
NH2-terminal portion predicted to lie in an aqueous
environment and the C-terminal portion predicted to contain 6 transmembrane segments. Tryptic digests of sealed vacuolar vesicles and
immunofluorescence studies revealed that the large hydrophilic
NH2-terminal domain of the 95-kDa subunit is localized
toward the cytosol. This region therefore is ideally positioned to
interact with components of the V1 complex, potentially
functioning as the elusive link between the two sectors of the
V-ATPase.
 |
INTRODUCTION |
Vacuolar-type H+-ATPases
(V-ATPases)1 are multimeric
complexes that mediate the luminal acidification of various organelles (e.g. yeast and plant vacuoles, endosomes, lysosomes,
phagosomes, and clathrin-coated vesicles) (for review, see Ref. 1).
Organellar acidification is essential for a variety of cellular
processes, including receptor-mediated endocytosis, processing and
proteolysis of proteins, intracellular degradation of ingested
pathogens and proton-coupled transport of small molecules. The V-ATPase
complex contains two distinct structural sectors, a peripheral
catalytic complex (V1) mediating ATP hydrolysis and a
membrane-associated complex (V0) defining the proton
channel proper (for review, see Ref. 1).
The soluble catalytic sector of the yeast V-ATPase consists of at least
8 subunits. The catalytic core is composed of a hexamer formed by
alternating 69-kDa (Vma1p or A) and 60-kDa (Vma2p or B) subunits
symmetrically arranged to generate a hollow core through the middle of
the sphere. Vma1p and Vma2p both contain consensus sequences for
ATP-binding domains; Vma1p has been ascribed a catalytic function,
whereas Vma2p is thought to have a regulatory function. The hollow core
formed by the ATP-binding subunits contains a central stalk, which is
likely composed of the Vma4p, Vma7p, Vma8p, and Vma10p subunits (27, 14, 32, and 13 kDa, respectively) (2). The function of the
V1 subunits Vma13p (54 kDa) and Vma5p (42 kDa) is not known.
The membrane-bound V0 complex is composed of at least 5 subunits. The proteolipid believed to form the proton channel (3) is
encoded by three genes, VMA3 (17 kDa), VMA11 (17
kDa), and VMA16 (23 kDa) (4). The 100-kDa V0
subunit is encoded in yeast by VPH1 (5) and STV1
(6). Vph1p and Stv1p are functional homologues, but they are targeted
to different organelles within the cell, suggesting that this subunit
is involved in the differential regulation of V-ATPase activity. The
function of the 36-kDa V0 subunit, Vma6p, is not known.
The V-type and the mitochondrial F-type ATPases share a common
structural architecture. The F-type ATPases are also defined by a
bipartite structure with a hydrophilic catalytic sector
(F1) and a hydrophobic proton-conducting component
(F0) (7). The crystal structure of the F1
ATPase sector shows the catalytic (
) and regulatory (
) subunits
arranged in an alternating hexagonal circular array, with the
nucleotide binding sites localized to the
-
interface (8). The
catalytic binding sites are located in the
-subunit with the
noncatalytic sites restricted to the
-subunit. Because of the
structural similarity between the ATPases, the catalytic and
noncatalytic nucleotide binding sites in the V1 sector are
likely to be similarly arranged.
Several lines of evidence substantiate that the A subunit of the
V-ATPases contains the catalytic binding sites. The A subunit contains
all the consensus loops, including a glycine-rich loop region (9) that
was identified as critical for ATP hydrolysis in the
-subunit of the
F-ATPases. In addition, the inhibitors N-ethylmaleimide and
7-chloro-4-nitrobenz-2-oza-1,3-diazole label the A subunit by
covalently modifying a critical cysteine residue in the ATP binding
site (10, 11). Site-directed mutagenesis of a single cysteine residue
within the glycine-rich loop yields a fully active protein resistant to
both inhibitors (12, 13). Finally, photolabeling of the A subunit with
2-azido-[32P]ATP correlates directly with inhibition of
ATPase activity (14).
Current experimental evidence suggests that the nucleotide binding
sites within the B subunit are noncatalytic. Although modification with
photoaffinity analogues (3-0-(4-benzoyl)benzoyl-ATP (15) and
2-azido-[32P]ATP (14) has demonstrated the presence of
nucleotide binding sites within the B subunit, there is little evidence
to suggest that these sites are catalytic in nature. The absence of a
glycine-rich consensus sequence within the B subunit supports this conclusion.
The impact of nucleotide binding on the conformation of the
V1 catalytic and regulatory subunits remains unclear. The
available data is contradictory; some evidence suggests that ATP
binding to the catalytic subunit does not induce a conformational
change, as assayed by alterations in sensitivity to proteolytic
degradation (16). Conversely, conditions optimal for ATP hydrolysis
promote the dissociation of the peripheral sector from the membrane,
suggesting that catalysis induces a conformational change within
V1 that facilitates its release (17, 18). Site-directed
mutagenesis of the yeast catalytic subunit demonstrated that loss of
activity impaired removal of the peripheral complex by KNO3
(19). These data strongly suggest that the catalytic subunit alters its
conformation in response to substrate binding and/or hydrolysis.
Dissociation of the V1V0 complex results in a
loss of proton translocation and ATP hydrolysis, with complex
reassociation restoring both activities (20, 21). The ability to
reassociate into an active complex demonstrates that both sectors are
functionally interdependent although remaining structurally independent
in isolation. The structural independence of the two sectors has been
demonstrated in vivo (22). Mutants lacking a single subunit of the enzyme yielded assembled cytosolic V1 sectors in the
absence of a V0 subunit, and membrane-associated assembled
V0 sectors in the absence of a V1 constituent
(22). Despite their structural autonomy, physical coupling of the two
sectors is essential for activity, suggesting that protein subunits of
a given sector may be responsive to conformational changes within its
functional counterparts. As physical interactions between the two
sectors is an absolute requirement for function, a number of structural links must exist to allow for sector interaction. To date, no such link
has been identified for V-ATPases. Here, we present evidence suggesting
that Vph1p is part of the structural link.
The Vph1p subunit is unique to V-ATPases. Hydropathy analysis of Vph1p
predicts two distinct structural domains, a hydrophilic NH2-terminal domain (~50 kDa) and a hydrophobic
C-terminal domain (~50 kDa) that contains 6-8 putative
membrane-spanning regions. Through the use of limited proteolysis of
intact vacuolar membranes and immunoblotting, as well as
immunofluorescence, we have unambiguously localized the NH2
terminus of Vph1p to the cytosol. The disposition of the
NH2-terminal Vph1p domain toward the cytosolic space would permit physical interactions of Vph1p with protein subunits of the
V1 sector. Because of its unique bipartite structure and
its structural responsiveness to substrate binding, we propose that Vph1p is ideally suited to serve as a structural and functional link
between the two sectors of the V-ATPase.
 |
EXPERIMENTAL PROCEDURES |
Materials and Strains--
Zymolyase was purchased from
ICN Biochemicals and bafilomycin A1 from Kamiya Biomedical
Company. The strains of Saccharomyces cerevisiase used were
the protease-deficient BJ926 (Mata/
, trp1/+, +/his1,
prc1-126/prc1-126, pep4-3/pep4-3, prb1-1122/prb1-1122, can1/can1,
gal2/gal2), MM108 (Mat
vma1
::URA3, his4,
ura3-52) bearing a disruption of the 69-kDa catalytic subunit
(Vma1p), and MM53 (
ura3-52
vph1::LEU2),
which bears a disruption of the 95-kDa V-ATPase subunit, Vph1p. The
strain BJ1991 (Mat
pep4-3, leu2, trp1, ura3-52,
prbl-1122) was also used. The protease-deficient yeast strain PK22
(Mat
pep4-3, vma2
1, ura3-52, his4-519, ade6, gal2)
that is disrupted for the 60-kDa regulatory subunit, Vma2p, was kindly
supplied by Dr. Patricia M. Kane, State University of New York Health
Science Center, Syracuse, NY. Wild type yeast cells were grown
overnight in 1% yeast extract (Difco), 2% bacto-peptone (Difco), and
2% dextrose (YEPD medium). The
vma1 and
vma2 strains were grown in YEPD adjusted to pH 5.0 with
HCl, because cells lacking vacuolar ATPase activity grow optimally in
acidified medium (23).
Purification of Vacuolar Membranes--
Isolation of
transport-competent vacuolar membrane vesicles through flotation of
intact vacuoles on Ficoll gradients was performed as described in (5).
Protein concentrations of vacuolar vesicles were measured by Lowry assays.
Proteolysis of Purified Vacuolar Membranes--
Purified
vacuolar membranes were subjected to controlled trypsin proteolysis in
the following manner: 20 µg of purified vacuolar membranes in 25 mM MES/Tris, pH 7.8, 25 mM KCl were incubated with varying concentrations of trypsin at 37 °C for 2 h. In
addition, 5 mM of nucleotide (ATP, ADP, or ATP
S) and 5 mM divalent cation (MgCl2 or CaCl2)
were included during proteolysis as indicated for each experiment. The
final reaction volume was 100 µl. Trypsin proteolysis was inhibited
by the addition of phenylmethylsulfonyl fluoride to a final
concentration of 1 mM and tosyl-L-lysine
chloromethyl ketone to a final concentration of 5 mM
followed by incubation on ice for 15 min. Samples were denatured by the
addition of 5× SDS sample buffer, assayed by SDS-PAGE (24), and
immunoblotting as described by Olmsted (25).
Proteolytic digests performed in the presence of ADP or ADP·Mg were
treated as described above with a final concentration of 5 mM ADP and 5 mM MgCl2. Samples
prepared in the presence of bafilomycin A1 were
preincubated for 10 min at room temperature. Bafilomycin A1
was prepared in Me2SO and added to a final concentration of
1 µM. Control samples were corrected for the addition of
Me2SO.
Vacuolar Integrity--
The integrity of the purified vacuolar
membranes to exogenously added proteases was assayed by the ability of
protease K to cleave pro-carboxypeptidase Y (CPY) to its mature form in
the absence and presence of detergent. Intact vacuoles purified from BJ1991 were resuspended at 0.5 µg/µl in 10 mM MES-Tris,
pH 6.9, and 30 µg/ml protease K in the presence or absence of 0.5%
(w/v) Triton X-100 for 0, 2, 10, and 20 min, respectively. Proteolytic digests were terminated at the designated times with the addition of
phenylmethylsulfonyl fluoride to a final concentration of 22.2 mM followed immediately by protein precipitation with
ice-cold 20% trichloroacetic acid. Protein pellets were washed in
ice-cold acetone to remove residual acid and denatured for SDS-PAGE
followed by immunoblotting with a monoclonal antibody to CPY, 10A5-B5
(Molecular Probes).
Raising of NH2 Terminus Vph1p Antibody and Affinity
Purification--
The antigen for immunization of the rabbits was
keyhole limpet hemocyanin-conjugated via a cysteine group to the
nonadecapeptide (VSEL[E
G]ELG[K
L]VQFRDLNPDV) corresponding to residues 26 to 44 of the rat
116-kDa subunit, with bolded residues changed as indicated to
correspond more closely with the yeast Vph1p sequence. Each rabbit was
injected with 1 mg of peptide/carrier in Freund's complete adjuvant.
At days 20, 38, 45, and 60 each rabbit was re-injected with 1 mg of
labeled keyhole limpet hemocyanin in Freund's incomplete adjuvant.
Rabbits were sacrificed at day 70. Serum was collected by incubating
the rabbit's blood at 37 °C until coagulation, centrifuging the
sample, and then collecting the supernatant. Immunoglobulins were
precipitated from raw sera by 50%
(NH4)2SO4, the pellet was
resuspended to 50% of the original volume, and dialyzed overnight
against 10 mM Tris-HCl, pH 7.3, 0.9% NaCl. Whole yeast
homogenate prepared from a
vph1 mutant strain was
prepared as described (6), electrophoresed, and transferred to
nitrocellulose. The blot was incubated with blocking buffer routinely
used for immunoblotting (25). The dialysate and blot were incubated for
1 h to absorb any anti-yeast immunoglobulins with the obvious
exception of anti-Vph1p antibodies. Anti-NH2 terminus Vph1p
antibodies were purified using the method described by Manolson
et al. (5).
Antibodies--
ATPase subunits were detected with one of the
following antibodies: 1) a rabbit polyclonal antibody raised against
the catalytic 69-kDa V-ATPase A subunit purified from Beta
Vulgaris L. (described in Ref. 26); 2) a rabbit polyclonal
antibody directed against the regulatory 60-kDa B subunit of murine
V-ATPase (described in Ref. 27); 3) a monoclonal antibody directed
against the 60-kDa Vma2p subunit (clone 13D11-B2, Molecular Probes); 4)
a rabbit polyclonal antibody directed against full-length Vph1p
(described in Ref. 5); 5) a rabbit polyclonal antibody directed against the NH2 terminus of yeast Vph1p, as described above.
Immunofluorescence Microscopy--
Slides for immunofluorescence
were prepared exactly as described by Manolson et al. (6)
and were viewed with a Nikon epifluorescence Diaphot-TMD microscope.
Images were photographically recorded on Kodak TMAX film with resulting
pictures subsequently digitized. The primary antibodies used were as
follows: rabbit affinity-purified anti-Vph1p was diluted 1:50, and
rabbit affinity-purified anti-NH2 terminus Vph1p was
diluted 1:25. The secondary antibody used was CY3 at a dilution of
1:1,000.
Assignment of Putative Transmembrane Segments for
Vph1p--
Currently, 9 primary amino acid sequences, deduced from
cDNA, are available for the 95-kDa subunit of V-ATPase; yeast Vph1p (M89778), yeast Stv1p (V06465), rat Vpp1 (M58758), mouse TJ6 (M31226), Neurospora crassa (3929395), Caenorhabditis
elegans VPP1 (211115), human (Z711460), human osteoclast (U45285),
and bovine (L31770). Because multiple sequence-based secondary
structure predictions are substantially more accurate (28), the above
sequences were aligned and used to identify putative transmembrane
segments. These sequences were submitted to the PHD mail server
described by Rost et al. (29). The data obtained from the
PHD algorithm, coupled with topological data presented in this paper,
were utilized to generate a topological folding model of Vph1p.
 |
RESULTS |
Limited Proteolysis of Vacuolar H+-ATPase Demonstrates
That ATP·Mg Induces Conformational Changes in the Catalytic Subunit,
Vma1p--
Physical coupling of the V1 and V0
subunits is a requirement for catalysis and proton translocation.
Consequently, structural changes within one sector likely impact on the
conformation of the other sector. Moreover, dissociation of
V1 from V0 is enhanced in the presence of
ATP·Mg, suggesting that substrate binding results in conformational
changes within the V1 sector, allowing for its release.
These issues were addressed by a careful analysis of conformational
changes induced within subunits of both sectors, as assayed by limited
trypsin proteolysis.
Analysis of conformational changes induced within the catalytic and
regulatory subunits of the V-ATPase by nucleotide, cofactor, and
inhibitor binding was undertaken. Limited tryptic digests of purified
vacuolar membranes were performed in the presence of nucleotides (ATP
or ADP) and/or magnesium. Proteolytic products were resolved by
SDS-PAGE and visualized by immunoblotting with antibodies directed
against the catalytic subunit, Vma1p (Fig. 1). As previously noted (16), ATP had no
protective effect on the catalytic subunit. Also, neither ADP nor
ADP·Mg had a protective effect on Vma1p (Fig. 1, panels B
and C). In contrast, the rate of trypsinization of Vma1p was
retarded in the presence of ATP·Mg (Fig. 1, panel E,
lane 4). These results demonstrate that only the endogenous
V-ATPase substrate can induce a conformational change in the catalytic
subunit.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 1.
Protection of the catalytic V-ATPase subunit,
Vma1p, from proteolytic degradation by ATP·Mg. Tryptic digests
of purified vacuolar membranes were performed at 37 °C for 2 h
in 25 mM MES/Tris, pH 7.8, 25 mM KCl and for
panel B, 5 mM ADP; panel C, 5 mM ADP and 5 mM MgCl2; panel
D, 5 mM ATP; and panel E, 5 mM
ATP and 5 mM MgCl2. Final trypsin
concentrations were 0.01, 0.05, 0.1, 0.5, 1.0, and 2.5 µg/ml, as
indicated above the panels. Lanes 1-4 contain 2 µg of
total vacuolar protein. Immunoblots were probed with a polyclonal
antibody directed against the plant catalytic A subunit (26).
|
|
Limited Proteolysis of Vacuolar H+-ATPase Demonstrates
That ATP·Mg Induces Conformational Changes in the Regulatory Subunit,
Vma2p--
Photolabeling experiments have identified a nucleotide
binding site on Vma2p, a putative regulatory subunit of the V-ATPase complex (14, 15, 30). A reconstituted recombinant subunit B
can be labeled by radioactive nucleotides in a divalent cation (Mg2+ and Ca2+)-dependent manner
(30). Previous studies have reported that ATP did not alter the pattern
or rate of trypsinization of the B subunit (16). Given that ATP·Mg
renders the catalytic subunit resistant to trypsin proteolysis and that
ATP labeling of the B subunit is cation-dependent,
experiments were undertaken to determine whether the presence of
nucleotides and/or cations alter the proteolytic susceptibility of Vma2p.
Partially purified vacuolar membranes were treated with increasing
concentrations of trypsin in the absence or presence of ATP.
Proteolytic products were resolved by SDS-PAGE and assayed by
immunoblotting (Fig. 2, panels
A and B) with two different antibodies to identify the
maximum number of trypsin-generated peptides. Vma2p was more sensitive
than the catalytic subunit to proteolytic degradation under all
conditions assayed, requiring the use of much lower trypsin
concentrations (0.01 µg/ml to 0.25 µg/ml). Trypsin degradation of
Vma2p was accelerated in the presence of ATP (Fig. 2, panels
A and B, lanes 6-9) and further enhanced with ATP·Mg (Fig. 2, panels A and B,
lanes 10-13). Particularly striking was the generation of a
30-kDa peptide in samples treated with 0.25 µg/ml trypsin in the
presence of ATP·Mg (indicated by line). This peptide was not detected
in samples treated with identical trypsin concentrations in the absence
of nucleotide and cofactor. The 30-kDa peptide is not the result of a
novel cleavage site unmasked by the presence of ATP·Mg, because an
identical product was detected in samples treated with higher trypsin
concentrations (>0.3 µg/ml) in the absence of nucleotide and/or
magnesium. This result demonstrates increased proteolytic
susceptibility of Vma2p in the presence of ATP·Mg. The question
remains as to whether these nucleotide-mediated conformational effects
are due to direct binding to Vma2p or a consequence of nucleotide
binding to Vma1p. Efforts to restrict nucleotide binding (via
photolabeling with azido-ATP) to Vma1p to determine whether labeling at
the catalytic site was sufficient to render the Vma2p more
proteolytically sensitive, proved inconclusive.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 2.
Increased proteolytic susceptibility of the
regulatory V-ATPase subunit, Vma2p, in the presence of ATP and
ATP·Mg. Tryptic digests of purified vacuolar membranes were
performed at 37 °C for 2 h in 25 mM MES/Tris, pH
7.8, 25 mM KCl with the addition of 5 mM ATP
for lanes 6-9 and 5 mM ATP and 5 mM
MgCl2 for lanes 10-13. Final trypsin
concentrations were 0.01, 0.05, 0.1, and 0.25 µg/ml, as indicated
above the panels. All lanes contain 2 µg of purified total vacuolar
proteins. Panel A, immunoblot was probed with a monoclonal
antibody directed against the yeast regulatory subunit. Panel
B, immunoblot was probed with polyclonal antibody directed against
the rat regulatory B subunit (27). Arrowhead indicates size
of full-length protein. A small proteolytic (30 kDa) generated in the
presence of ATP·Mg is indicated by a line at the figure margin.
|
|
Limited Proteolysis of the Vacuolar H+-ATPase Reveals
Distinct ATP and Mg2+-induced Conformational Changes in
Vph1p, the 95-kDa Subunit of the V0 Sector--
Incubation
of the V-ATPase complex with ATP·Mg leads to the dissociation of the
V1 sector from the membrane-bound V0 sector (18). Preincubation of V-ATPases with N-ethylmaleimide at
inhibiting concentrations prevents release of the V1 sector
(11). This observation, coupled with data presented here, suggests that
ATP·Mg binding induces a dramatic conformational change within Vma1p and Vma2p. This structural change, once transmitted to the remaining complex, allows for dissociation of the two sectors. Thus binding of
ATP·Mg to the catalytic and regulatory subunits may induce a
conformational change(s) in additional subunits within the V-ATPase complex. Of particular interest are conformational changes induced within the V0 complex, demonstrating a structural
interdependence between the two sectors.
Our efforts focused on the 95-kDa subunit (Vph1p) for a number of
reasons. Hydropathy analysis of Vph1p predicts a large hydrophilic amino-terminal domain and a hydrophobic C-terminal domain with 6-8
putative transmembrane segments (5). Although the topology of Vph1p has
not been elucidated, proteolytic digests and labeling with impermeant
reagents have demonstrated that regions of the protein are
cytosolically exposed (31, 32). Because of its dual domain structure,
the 95-kDa subunit is potentially available to interact with the
V1 and V0 sectors (5). This hypothesis is
supported by the finding that Vph1p is required for the proper assembly
of V0 and the functional association of the two sectors (33). Because Vph1p appears to be required for the structural coupling
of V1 and V0 complexes, it may be responsive to
conformational changes occurring within the peripheral sector. To
determine whether this was the case, the following experiments were
performed. Under routine purification conditions, the 95-kDa subunit is
rapidly cleaved to a ~ 80-kDa peptide product by endogenous
vacuolar proteases. Isolation of vacuoles from pep4-3
strains, in which proteinase A-dependent proteases are
inactive, yields only the full-length 95-kDa protein (5). All vacuoles
used for tryptic digests were purified from protease-deficient strains
to avoid confounding effects due to endogenous proteases. Tryptic
digests of vacuolar membranes in the presence of either ATP or
Mg2+ were performed, the trypsinized samples were resolved
by SDS-PAGE, and assayed by immunoblotting with anti-Vph1p antibodies.
Vph1p appears to undergo conformational changes in response to ATP and Mg2+. Samples digested in the presence of ATP were degraded
less rapidly compared with controls (Fig.
3, ATP). Focusing on samples treated with
2.5 µg/ml trypsin (Fig. 3, lanes 7, 13, and
19), it is clear that production of the smallest peptide
product (indicated by a line) decreases with inclusion of ATP and,
surprisingly, increases when digests are performed in the presence of
magnesium. These results suggest that the conformation of Vph1p is
responsive to both ATP and magnesium.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 3.
Variable proteolytic susceptibility of the
95-kDa V-ATPase subunit, Vph1p, in the presence of ATP or
magnesium. Tryptic digests of purified vacuolar membranes were
performed at 37 °C for 2 h in 25 mM MES/Tris, pH
7.8, 25 mM KCl with the addition of 5 mM ATP
(ATP) and 5 mM MgCl2
(Mg2+). Control shows samples
digested in the absence of nucleotide or divalent cation. Final trypsin
concentrations were 0.01, 0.05, 0.1, 0.5, 1.0, and 2.5 µg/ml, as
indicated above the three panels. All lanes contain 2 µg of purified
total vacuolar proteins. Immunoblots were probed with a polyclonal
antibody directed against the yeast 95-kDa subunit. The
arrow indicates size of full-length protein.
|
|
To date, no ATP or cation binding sites have been identified within the
95-kDa subunit (5). Ruthenium red binding has been successfully used to
identify a number of cation binding proteins (34). No ruthenium red
binding was detected for purified Vph1p (data not shown), confirming
that Vph1p does not bind divalent cations. Thus, conformational changes
induced by divalent cations or ATP must occur through their binding to
other proteins within the V-ATPase complex. Clearly, the catalytic and
regulatory subunits are likely candidates given that both bind
nucleotides and divalent cations and undergo marked conformational
perturbations upon binding. The data suggest that conformational
changes induced by substrate binding to the V1 sector are
transmitted to Vph1p. In this case, removal of the peripheral sector
should render Vph1p insensitive to either nucleotide or divalent
cations and the rate of proteolysis should be unaffected by the
presence of either compound.
To test this model, membranes were purified from a protease-deficient
yeast strain lacking a functional copy of the gene encoding the 60-kDa
regulatory subunit of V-ATPase (
vma2). In the absence of
Vma2p, the remaining peripheral subunits fail to associate with the
vacuolar membrane (23, 35). V0 complexes in the
vma2 vacuolar membrane are functionally competent and
reassemble with wild type V1 subunits, as assayed by
restoration of ATPase activity (36) demonstrating that the isolated
V0 complex adopts a native structure. Thus, membranes
isolated from a
vma2 strain are a suitable source for
isolated, intact, and fully assembled V0 sectors.
Although the isolated V0 sector was more susceptible to
trypsin proteolysis than the intact complex, no difference in the rate
of degradation was noted in the presence of ATP or magnesium (Fig.
4). The increased susceptibility to
proteolytic degradation of the isolated V0 sector suggests
that absence of V1 renders the membrane sector more
accessible to the protease. This enhanced proteolytic sensitivity is
consistent with previous reports that noted an increased rate of
proteolysis for V0 sectors reconstituted in the absence of
the peripheral sector (37). No novel proteolytic sites were detected,
nor were tryptic sites lost in Vph1p. This suggests that the exposed
regions of Vph1p do not undergo gross conformational changes in the
absence of the V1 complex. The observation that Vph1p has
become conformationally insensitive to ATP and divalent cations
suggests that the subunit itself does not bind to either of these
compounds. Rather, it is the binding of ATP and divalent cations to the
V1 sector that transmits conformational changes to
Vph1p.

View larger version (73K):
[in this window]
[in a new window]
|
Fig. 4.
Absence of the peripheral sector abolishes
the increased rate of proteolysis of Vph1p in the presence of
magnesium. Vacuolar membranes were purified from a
protease-deficient yeast strain lacking a functional copy of the gene
encoding the 60-kDa regulatory subunit of V-ATPase
( vma2). V0 complexes in the
vma2 vacuolar membrane are functionally competent for
reassembly with wild type V1 subunits, as assayed by
restoration of ATPase activity (36). Tryptic digests of purified
vacuolar membranes were performed at 37 °C for 2 h in 25 mM MES/Tris, pH 7.8, 25 mM KCl with the
addition of 5 mM MgCl2 for the lower
panel. The upper panel shows samples digested in the
absence of nucleotide or divalent cation. Final trypsin concentrations
were 0.01, 0.05, 0.1, 0.5, 1.0, and 2.5 µg/ml, as indicated above the
panels. All lanes contain 2 µg of purified total vacuolar proteins.
The middle and lower panels show samples digested
under identical conditions with the exception that 5 mM
MgCl2 (Mg2+) or 5 mM ATP
(ATP) was added. Both immunoblots were probed with a
polyclonal antibody directed against the yeast 95-kDa subunit. The
arrow indicates size of full-length protein.
|
|
Binding of Bafilomycin A1, an Inhibitor of V-ATPase
Activity, Induces Conformational Changes in the Vma1p
Subunit--
Bafilomycin A1, a potent microlide inhibitor
of vacuolar-type ATPases, binds to the membrane-associated sector
(V0) of the complex (3, 38, 39). Specifically, it appears
that the inhibitor binding site is contained within Vph1p. To determine whether bafilomycin A1 binding has an effect on the
structure of Vph1p, partially purified vacuolar membranes were
trypsinized in the presence of inhibitor. In addition to bafilomycin
A1, digests were performed in the presence and absence of
ATP and/or magnesium. Vacuolar membranes were preincubated with
bafilomycin A1 for 10 min to ensure that inhibitor binding
was not prevented by nucleotides or divalent cations. Samples were
trypsinized, as described previously, and the generated peptides
resolved by SDS-PAGE and assayed by immunoblotting. The presence of
bafilomycin A1 did not alter the rate of proteolytic
degradation of Vph1p (data not shown). This result may indicate that
inhibitor binding to Vph1p does not cause a structural change within
Vph1p. Alternatively, inhibitor binding may occur within the
hydrophobic region of Vph1p and thus any conformational changes would
not be detected by the use of antibodies targeted to hydrophilic
surface epitopes.
Bafilomycin A1 alone or in the presence of nucleotide and
cofactor rendered Vma1p more susceptible to proteolytic degradation (Fig. 5). This unexpected result
indicates that binding of bafilomycin A1 to Vph1p induces a
conformational change in the catalytic subunit of the V-ATPase.
Surprisingly, samples trypsinized in the presence of ATP and
bafilomycin A1 were most susceptible to proteolytic degradation (Fig. 5, lanes 5-7). Similar treatment in the
presence of ATP·Mg was noted to minimize the effect of bafilomycin
A1 on the proteolytic susceptibility of Vma1p (Fig. 5,
lanes 8-10). These data suggest that a reciprocal
structural relationship exists between the peripheral and
membrane-associated sectors of the V-ATPase. As inhibitor binding to
V0 induces a conformational change in the catalytic subunit
of V1, cation binding to the peripheral sector induces a
structural alteration in the membrane-bound complex.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 5.
The catalytic V-ATPase subunit, Vma1p, is
more susceptible to proteolysis in the presence of bafilomycin
A1. Tryptic digests of purified vacuolar membranes
were performed at 37 °C for 2 h in 25 mM MES/Tris,
pH 7.8, 25 mM KCl with the addition of 5 mM ATP
for lanes 5-7 and 5 mM ATP and 5 mM
MgCl2 for lanes 8-10. Samples
treated in the presence of inhibitor contained bafilomycin
A1 to a final concentration of 1 mM. Final
trypsin concentrations were 0.1, 1.0, and 2.5 µg/ml, as indicated
above the panels. All lanes contain 2 µg of purified total vacuolar
proteins. Immunoblots were probed with a polyclonal antibody directed
against the plant catalytic subunit (26).
|
|
Localization of the NH2 Terminus of Vph1p to the
Cytosol--
Results presented here indicate that Vph1p is responsive
to conformational changes that originate within the peripheral sector (ATP·Mg binding to V1 sector) and conversely, that
structural changes occurring within the 95-kDa subunit (bafilomycin
A1 binding to Vph1p) can impact on the structure of the
V1 sector. Clearly, the 95-kDa subunit must establish
extensive protein-protein interactions to mediate such a degree of
intersector communication. Current topological models of Vph1p (40)
localize the extensive hydrophilic amino terminus to the vacuolar
lumen. If disposed toward the cytosol, this large region of Vph1p would
be an ideal candidate to serve as the structural link between the
membrane-associated and the peripheral sectors.
The cellular location of the NH2 terminus of Vph1p was
established by the following experiments. An antibody directed against the NH2 terminus of yeast Vph1p was raised in rabbits and
affinity purified as detailed under "Experimental Procedures."
Intact purified vacuolar membranes were trypsinized and proteolytic
products were assayed by immunoblotting. Proteolytic cleavage at low
trypsin concentrations (0.1 µg/ml) generated a single peptide product of approximately 90 kDa in size (Fig. 6,
panel A), indicating the loss of either the N or C terminus
of Vph1p. The failure of an antibody directed against the extreme
NH2 terminus of yeast Vph1p to recognize the 90-kDa product
peptide demonstrates that this fragment does not contain this region of
the protein (Fig. 6, panel A). This result suggests that the
NH2 terminus of Vph1p is disposed toward the cytosol.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 6.
The NH2 terminus of Vph1p is
localized to the cytosol. Panel A, tryptic digests of intact
vacuolar membranes were performed at 37 °C for 2 h in 25 mM MES/Tris, pH 7.8, 25 mM KCl with a final
trypsin concentration of 0.01 µg/ml for lane 2 and 1.0 µg/ml for lane 3. All lanes contain 5 µg of purified
vacuolar membrane proteins. The upper panel was probed with
a polyclonal antibody directed against the full-length Vph1p. The
lower panel was probed with a polyclonal antibody directed
against the extreme NH2 terminus of yeast Vph1p. The
full-length protein is indicated by a line at the left margin.
Panel B, the integrity of the purified vacuolar membranes to
exogenously added proteases was assayed by the ability of protease K to
cleave pro-CPY (pCPY)to its mature form in the absence and
presence of detergent. Pro-CPY and its mature form are normally
sequestered in the vacuolar lumen. Intact vacuoles were treated with
protease K (final concentration, 30 µg/ml) in the presence or absence
of 0.5% (w/v) Triton X-100 for 0, 2, 10, and 20 min, respectively.
Following trichloroacetic acid precipitation, the protein pellets were
denatured and resolved by SDS-PAGE. Both immunoblots shown were probed
with a commercially available monoclonal antibody to CPY. The
full-length pro-protein (66 kDa) is indicated by a line at the left
margin, whereas the processed form of carboxypeptidase Y is indicated
by an arrow. Panel C, wild type (WT)
and vma1p, a Vma1p disruption mutant, were grown on
complete medium as required. The cells were fixed, spheroplasted,
permeabilized, and mounted onto slides as detailed under
"Experimental Procedures." Cells were labeled with rabbit
anti-full-length Vph1p ( -Vph1p) or rabbit
anti-NH2 terminus Vph1p ( -NH2 terminus
Vph1p) followed by CY3 conjugated goat anti-rabbit IgG. Identical
fields are shown as viewed under Nomarski optics (Nomarski)
and CY3 fluorescence optics (Fluorescence).
|
|
Accurate interpretation of these results requires confirmation of the
membrane integrity of the purified vacuoles. Access to the vacuolar
lumen would allow for the proteolytic cleavage of an NH2
terminus disposed toward the luminal space. To confirm the integrity of
the vacuolar membrane, purified vacuoles, containing the luminally
sequestered pro-form of carboxypeptidase Y (pro-CPY), were subjected to
proteinase K digestion in the presence and absence of detergent (Triton
X-100). Conversion of the pro-form of the enzyme to the mature form
(CPY) was utilized as a marker for access by the protease to the
vacuolar lumen. Samples were treated with (30 µg/ml) proteinase K for
0, 2, 10, or 20 min. Pro-CPY was only converted to the mature enzyme
form in the presence of detergent (Fig. 6, panel B).
Incubation of the purified vacuolar membranes with proteinase K for up
to 20 min failed to generate cleaved CPY in the absence of detergent.
Clearly, purified vacuolar membranes are sealed and able to exclude
proteases from the luminal interior.
The cellular location of the NH2 terminus of Vph1p was
confirmed by the use of immunofluorescence. A wild type yeast strain (BJ926) and a
vma1 strain (MM108) containing only
assembled V0 complexes were used. The cells were fixed,
spheroplasted, permeabilized, and mounted onto slides as described
under "Experimental Procedures." As has been previously reported
(41), vacuolar morphology of the wild type and mutant strains are
indistinguishable under Nomarski optics (Fig. 6, panel C).
The vacuolar membranes of the wild type and
vma1 strain
showed comparable staining with an antibody directed against
full-length Vph1p, which indicates that there are similar levels of
expression and localization between the two yeast strains of the 95-kDa
subunit. Differences were seen when the membranes were stained with the
antibody directed against the NH2 terminus of Vph1p. Wild
type vacuolar membranes showed minimal staining, whereas the
vma1 strain showed levels of vacuolar staining comparable with that obtained with the antibody directed against the full-length protein. The presence of the V1 subunit inhibits binding of
the anti-NH2 terminus Vph1p antibody. This indicates that
the NH2 terminus is localized to the cytosol and that it
interacts with the V1 to the extent that the peripheral
sector can block antibody binding. The topology of the C terminus has
not been resolved, yet sequence analysis predicts at least 6-8 regions
of sufficient length and hydrophobicity to function as
membrane-spanning domains (5). To more accurately predict transmembrane
segments, multiple sequence-based secondary structure predictions (as
described in Ref. 29) were performed on the nine known protein
sequences encoding the 95/116-kDa V0 subunit. The data
obtained from the PDH algorithm, coupled with the topological data
presented in this paper, were used to generate the topological folding
model presented in Fig. 7.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 7.
Topological folding model of yeast
Vph1p. The membrane domain of yeast Vph1p (residue 461-844) is
proposed to span the membrane bilayer 6-8 times. Transmembrane
segments were identified using the PHD algorithm. The hydrophilic
NH2 terminus (residues 1-460) is localized toward the
cytosol. Transmembrane segments are labeled TM 1-8. No experimental
data is currently available on the topology of the transmembrane
domain. The algorithm employed predicts a minimum of 6 transmembrane segments with a possible 8 membrane-spanning regions in
the C terminus of Vph1p. Residues indicating the limits of the TM
segments are indicated on the figure. Hatched TM segments were
difficult to assign with certainty. In particular, TM7 and TM8
represent a long hydrophobic stretch (~30 residues) that could exist
as a single TM domain or as two shorter TM segments.
|
|
 |
DISCUSSION |
The vacuolar ATPase is composed of two structural sectors
(V1 and V0) that perform distinct functions,
ATP hydrolysis and proton translocation. The sectors are functionally
coupled with complex dissociation rendering both inactive. As
demonstrated by this work, this is a dynamic relationship with
substrate or inhibitor binding to one sector inducing conformational
alterations within both complexes. The study was initiated by examining
the impact of substrate binding on subunits (Vma1p and Vma2p) of the catalytic sector.
Nucleotide-induced conformational changes within the catalytic and
regulatory subunits of the V-ATPase were monitored by alterations in
susceptibility to trypsin proteolysis. Our results concur with previously published data that ATP alone has no protective effect on
the catalytic subunit (16). Similarly, the binding of ADP or ADP·Mg
did not protect Vma1p from proteolytic degradation, suggesting that
occupancy of the catalytic site by ADP·Mg does not dramatically alter
the conformation of Vma1p. Conversely, ATP·Mg does induce a
conformational change within the catalytic subunit as demonstrated by
its increased resistance to proteolytic degradation. To determine
whether ATP hydrolysis, rather than ATP binding, was required to induce
the observed conformational change, purified vacuolar membranes were
trypsinized in the presence of ATP
S, a nonhydrolyzable ATP analogue.
Trypsinization in the presence of ATP
S generated a proteolytic
pattern indistinguishable from that obtained with hydrolyzable
nucleotide (data not shown) under all conditions assayed (with or
without Mg2+). Although the experimental conditions used
allow for single site hydrolysis, it is clear that multisite catalysis
is not required to induce a conformational change in the catalytic subunit.
The proteolytic susceptibility of Vma2p was increased in the presence
of ATP and further enhanced in the presence of ATP·Mg. Clearly,
substrate binding dramatically alters the conformation of the
regulatory subunit. It remains unclear if this effect is due to
ATP·Mg binding at the catalytic site, although this suggestion is
indirectly supported by several lines of evidence. High resolution structural analysis of the F-ATPase peripheral sector suggests that
Vma1p and Vma2p come together to form a catalytic site that resides
primarily on Vma1p with some residues contributed by Vma2p (14, 42).
Because the catalytic site is essentially shared by the two subunits,
it is likely that binding of ATP·Mg alters both conformations. This
presumption is supported by studies of in vitro
reconstitution of the core V1 sector (subunits Vma1p, Vma2p, Vma4p, Vma7p, Vma8p, and Vma10p) showing that complex assembly is nucleated by the association of Vma1p and Vma2p with ATP·Mg stabilizing this critical interaction (2). These data suggest that binding of ATP·Mg likely induces a conformational change within
Vma1p and/or Vma2p, providing a stable core for the formation of higher
order complexes of the peripheral sector.
Compelling evidence indicates that ATP·Mg binding to the catalytic
subunit induces a global conformational change within the peripheral
sector, resulting in the dissociation of the soluble sector from the
membrane-associated complex. It has been proposed that "chaotropic"
anions mediate H+-ATPase inhibition by oxidizing critical
sulfhydryl residues, which in turn leads to the release of the
peripheral sector. Indeed, oxidation of these sites in the
Neurospora V-ATPase is associated with the rapid
dissociation of the V1 peripheral sector (43). In our
hands, although chaotropic agents (KI) enhanced removal of the
peripheral sector, ATP·Mg alone was sufficient to promote stripping
of the V1 sector (data not shown). This ATP·Mg-induced peripheral sector dissociation is inhibited by
N-ethylmaleimide modification of Vma1p. Clearly, substrate
binding induces a global conformational change within the peripheral
sector, allowing its release from the membrane-associated complex.
Dissociation was neither inhibited or reduced in the presence of
bafilomycin A1 or DCCD, potent inhibitors of V-ATPase
activity, suggesting that multisite hydrolysis is not required to
release the soluble V1 sector.
Of greater significance is the structural impact of substrate binding
(ATP and/or divalent cations) on the conformation of components of the
membrane-associated sector. Modification of the peripheral sector by
ATP or divalent cations resulted in a conformational change within
Vph1p, indicating that structural changes within the V1
sector impact on V0 components. There was a dramatic
increase in the rate of Vph1p proteolysis in the presence of divalent
cations (Mg2+, Ca2+, Mn2+)
supporting the conclusion that a degree of intersector communication exists within V-ATPases. Particularly intriguing is the importance of
divalent cations in maintaining the quaternary structure of the
peripheral domain. Reconstitution experiments involving the isolated subunits of the hydrophilic sector demonstrated that assembly
of the core was enhanced in the presence of divalent cations (2).
Mg2+, Ca2+, and Mn2+ were found to
be equally effective mirroring the pattern noted to increase the
proteolytic susceptibility of Vph1p. These results suggest that cation
binding induces a global conformational change that promotes formation
of a stable peripheral complex. Moreover, this cation-induced
conformational change is transmitted to the membrane-associated sector,
as evidenced by the increased proteolytic susceptibility of Vph1p. The
presence of cations did not enhance the rate of Vph1p proteolysis
within isolated V0 sectors, providing compelling evidence
that structural changes within Vph1p are mediated via intersector
communication versus direct cation binding to the
membrane-associated complex.
Data presented in this paper suggest that intersector communication is
bidirectional, with conformational changes initiated within the
membrane-associated sector reflected in a structural perturbation
within the peripheral sector and vice versa. The V-ATPase
inhibitor, bafilomycin A1, is known to bind to the
V0 complex, with evidence suggesting that its binding site
resides within Vph1p (3). Addition of bafilomycin A1
accelerated the rate of proteolysis of the catalytic subunit indicating
that inhibitor binding to the hydrophobic sector results in a
conformational change within Vma1p. Chromaffin granule V-ATPases show
simple Michaelis-Menten kinetics with three apparent
Km values (38). Addition of bafilomycin
A1 impairs ATP hydrolysis and catalytic cooperativity,
although hydrolysis at a single catalytic site remains resistant to the
inhibitor (38). This suggests that binding of bafilomycin
A1 to the hydrophobic sector impacts on the structure and
function of the hydrophilic sector, particularly the catalytic subunit.
A similar transmission of an inhibitory signal from the hydrophobic to
hydrophilic sector has been observed in the inhibition of
F0F1 ATPase by oligomycin and
dicyclohexylcarbodiimide (44). Thus, intersector communication is
reciprocal with conformational changes initiated within one sector
reflected in compensatory structural changes within the opposing complex.
The specific structural link(s) that mediates this intersector
communication remains unknown. Our work provides evidence that Vph1p
might play a central role in coupling the two sectors of the V-ATPase
with dynamic structural information readily transmitted between the
V0 and V1 sectors. Because of its bipartite
structure, Vph1p is an ideal candidate to serve as a functional and
structural link between the catalytic and proton-translocating sectors
of the V-ATPase. We have unambiguously localized the ~50-kDa
hydrophilic NH2 terminus of Vph1p to the cytosol, where it
is available to interact with the peripheral sector. Because of its
localization to the vacuolar membrane, the C-terminal domain of Vph1p
is in close proximity to the proton-translocating core of the V-ATPase, thus allowing for catalytically induced conformational changes within
the peripheral sector to impact on the functioning of the ion channel.
This model is supported by previous work demonstrating that mutagenesis
of key residues within the membrane-associated domain of Vph1p inhibits
both proton-translocation and ATPase activity (40, 45). This data
indicates that the C terminus of Vph1p is essential for H+
translocation and that changes to this region impacts on the function
of the catalytic sector. Thus, structural changes in the membrane
domain of Vph1p are capable of transmitting an inhibitory signal to the
catalytic sector, supporting that Vph1p mediates intersector communication.
Recent work on the structurally related F-type ATPases has revealed a
possible structural link between the F1 and F0
sectors (8). The 2.8 Å resolution structure of the soluble
F1 complex shows that a central stalk connects the soluble
and membrane-associated components of the F-type ATPase. The
- and
-subunits are arranged in an alternating hexagonal array with the
central pore of the structure occupied by two long
helices
contributed by the
-subunit. ATP hydrolysis drives the physical
rotation of the central
subunit (46, 47) that, in turn, drives
proton translocation. Efficient transduction of the torque exerted by
the rotating stalk on F0 requires the presence of a stator
(48, 49), which prevents loss of energy through the rotation of
F1 relative to F0. Subunits a,
(b)2, and
are likely candidates to fulfill this role in
the F-type ATPases (50). To date, no corresponding subunits have been
identified in the V-type ATPases, although a similar functional mechanism has been hypothesized. Because of its unique bipartite structure and its responsiveness to substrate binding, we propose that
Vph1p is ideally suited to serve as the structural and functional link between the two sectors of the V-ATPase and suggest that it is
part of the V-ATPase stator. Currently, work is underway to identify
regions of interaction between the hydrophilic sector of Vph1p and
components of the catalytic sector.
 |
ACKNOWLEDGEMENTS |
We thank Patricia M. Kane and Kelly Williams
for critical review of the manuscript. M. F. M also thanks Petra
Kuehl for moral support and patience.
 |
FOOTNOTES |
*
This work was supported by a Medical Research Council of
Canada operating grant (MT12053) and scholarship (to M. F. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Faculty of
Dentistry Research Institute, 124 Edward St., Rm. 429, Dept. of
Dentistry, University of Toronto, Toronto, Ontario M5G 1G6, Canada.
Tel.: 416-979-4900 (ext. 4392); Fax: 416-979-4936; E-mail:
m.manolson@utoronto.ca.
 |
ABBREVIATIONS |
The abbreviations used are:
V-ATPase, vacuolar-type proton-translocating adenosine triphosphatase;
DCCD, N,N'-dicyclohexylcarbodiimide;
PAGE, polyacrylamide gel electrophoresis;
ATP
S, adenosine
5'-O-(thiotriphosphate);
MES, 4-morpholineethanesulfonic acid;
CPY, carboxypeptidase Y;
TM, transmembrane.
 |
REFERENCES |
| 1.
|
Stevens, T. H.,
and Forgac, M.
(1997)
Annu. Rev. Cell Dev. Biol.
13,
779-808[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Tomashek, J. J.,
Graham, L. A.,
Hutchins, M. U.,
Stevens, T. H.,
and Klionsky, D. J.
(1997)
J. Biol. Chem.
272,
26787-26793[Abstract/Free Full Text]
|
| 3.
|
Zhang, J.,
Feng, Y.,
and Forgac, M.
(1994)
J. Biol. Chem.
269,
23518-23523[Abstract/Free Full Text]
|
| 4.
|
Hirata, R.,
Graham, L. A.,
Taktsuki, A.,
Stevens, T. H.,
and Anraku, Y.
(1997)
J. Biol. Chem.
272,
4795-4803[Abstract/Free Full Text]
|
| 5.
|
Manolson, M. F.,
Proteau, D.,
Preston, R. A.,
Stenbit, A.,
Roberts, B. T.,
Hoyt, M. A.,
Preuss, D.,
Mulholland, J.,
Botstein, D.,
and Jones, E. W.
(1992)
J. Biol. Chem.
267,
14294-14303[Abstract/Free Full Text]
|
| 6.
|
Manolson, M. F.,
Wu, B.,
Proteau, D.,
Taillon, B. E.,
Roberts, B. T.,
Hoyt, M. A.,
and Jones, E. W.
(1994)
J. Biol. Chem.
269,
14064-14074[Abstract/Free Full Text]
|
| 7.
|
Bowman, B. J.,
and Bowman, E. J.
(1996)
in
The Mycota III. Biochemistry and Molecular Biology
(Brambl, R.
, and Marzluf, G. A., eds), Vol. III
, pp. 57-83, Springer-Verlag, Berlin
|
| 8.
|
Abrahams, J. P.,
Leslie, A. G.,
Lutter, R.,
and Walker, J. E.
(1994)
Nature
370,
621-628[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Hirata, R.,
Ohsumk, Y.,
Nakano, A.,
Kawasaki, H.,
Suzuki, K.,
and Anraku, Y.
(1990)
J. Biol. Chem.
265,
6726-6733[Abstract/Free Full Text]
|
| 10.
|
Feng, Y.,
and Forgac, M.
(1992)
J. Biol. Chem.
267,
5817-5822[Abstract/Free Full Text]
|
| 11.
|
Feng, Y.,
and Forgac, M.
(1994)
J. Biol. Chem.
269,
13224-13230[Abstract/Free Full Text]
|
| 12.
|
Taiz, L.,
Nelson, H.,
Maggert, K.,
Morgan, L.,
Yatabe, B.,
Taiz, S. L.,
Rubinstein, B.,
and Nelson, N.
(1994)
Biochim. Biophys. Acta
1194,
329-334[Medline]
[Order article via Infotrieve]
|
| 13.
|
Liu, Q.,
Leng, X. H.,
Newman, P. R.,
Vasilyeva, E.,
Kane, P. M.,
and Forgac, M.
(1997)
J. Biol. Chem.
272,
11750-11756[Abstract/Free Full Text]
|
| 14.
|
Zhang, J.,
Vasilyeva, E.,
Feng, Y.,
and Forgac, M.
(1995)
J. Biol. Chem.
270,
15494-15500[Abstract/Free Full Text]
|
| 15.
|
Manolson, M. F.,
Rea, P. A.,
and Poole, R. J.
(1985)
J. Biol. Chem.
260,
12273-12279[Abstract/Free Full Text]
|
| 16.
|
Adachi, I.,
Arai, H.,
Pimental, R.,
and Forgac, M.
(1990)
J. Biol. Chem.
265,
960-966[Abstract/Free Full Text]
|
| 17.
|
Kane, P. M.,
Yamashiro, C. T.,
and Stevens, T. H.
(1989)
J. Biol. Chem.
264,
19236-19244[Abstract/Free Full Text]
|
| 18.
|
Moriyama, Y.,
and Nelson, N.
(1989)
J. Biol. Chem.
264,
3577-3582[Abstract/Free Full Text]
|
| 19.
|
Liu, J.,
and Kane, P. M.
(1996)
Biochemistry
35,
10938-10948[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Kane, P. M.
(1995)
J. Biol. Chem.
270,
17025-17032[Abstract/Free Full Text]
|
| 21.
|
Sumner, J. P.,
Dow, J. A.,
Earley, F. G.,
Klein, U.,
Jager, D.,
and Wieczorek, H.
(1995)
J. Biol. Chem.
270,
5649-5653[Abstract/Free Full Text]
|
| 22.
|
Doherty, R. D.,
and Kane, P. M.
(1993)
J. Biol. Chem.
268,
16845-16851[Abstract/Free Full Text]
|
| 23.
|
Noumi, T.,
Beltran, C.,
Nelson, H.,
and Nelson, N.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
1938-1942[Abstract/Free Full Text]
|
| 24.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Olmsted, J. B.
(1981)
J. Biol. Chem.
256,
11955-11957[Abstract/Free Full Text]
|
| 26.
|
Manolson, M. F.,
Percy, J. M.,
Apps, D. K.,
Xie, X.-S.,
Stone, D. K.,
Harrison, M.,
Clarke, D. J.,
and Poole, R. J.
(1989)
Biochem. Cell Biol.
67,
306-310
|
| 27.
|
Brisseau, G. F.,
Grinstein, S.,
Hackam, D. J.,
Nordstrom, T.,
Manolson, M. F.,
Khine, A. A.,
and Rotstein, O. D.
(1996)
J. Biol. Chem.
271,
2005-2011[Abstract/Free Full Text]
|
| 28.
|
Rost, B.,
and Sander, C.
(1993)
J. Mol. Biol.
232,
584-599[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Rost, B.,
Sander, C.,
and Schneider, R.
(1994)
Comput. Appl. Biosci.
10,
53-60[Abstract/Free Full Text]
|
| 30.
|
Peng, S. B.
(1995)
J. Biol. Chem.
270,
16926-16931[Abstract/Free Full Text]
|
| 31.
|
Adachi, I.,
Puopolo, K.,
Marquez-Sterling, N.,
Arai, H.,
and Forgac, M.
(1990)
J. Biol. Chem.
265,
967-973[Abstract/Free Full Text]
|
| 32.
|
Arai, H.,
Terres, G.,
Pink, S.,
and Forgac, M.
(1988)
J. Biol. Chem.
263,
8796-8802[Abstract/Free Full Text]
|
| 33.
|
Kane, P. M.
(1992)
J. Exp. Biol.
172,
93-103[Abstract/Free Full Text]
|
| 34.
|
Charuk, J. H. M.,
Pirraglia, C. A.,
and Reithmeier, R. A. F.
(1990)
Anal. Biochem.
188,
123-131[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Yamashiro, C. T.,
Kane, P. M.,
Wolczyk, D. F.,
Preston, R. A.,
and Stevens, T. H.
(1990)
Mol. Cell. Biol.
10,
3737-3749[Abstract/Free Full Text]
|
| 36.
|
Parra, K. J.,
and Kane, P. M.
(1996)
J. Biol. Chem.
271,
19592-19598[Abstract/Free Full Text]
|
| 37.
|
Zhang, J.,
Myers, M.,
and Forgac, M.
(1992)
J. Biol. Chem.
267,
9773-9778[Abstract/Free Full Text]
|
| 38.
|
Hanada, H.,
Moriyama, Y.,
Maeda, M.,
and Futai, M.
(1990)
Biochem. Biophy. Res. Commun.
170,
873-878[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Crider, B. P.,
Xie, X. S.,
and Stone, D. K.
(1994)
J. Biol. Chem.
269,
17379-17381[Abstract/Free Full Text]
|
| 40.
|
Leng, X. H.,
Manolson, M. F.,
Liu, Q.,
and Forgac, M.
(1996)
J. Biol. Chem.
271,
22487-22493[Abstract/Free Full Text]
|
| 41.
|
Kane, P. M.,
Kuehn, M. C.,
Howald-Stevenson, I.,
and Stevens, T. H.
(1992)
J. Biol. Chem.
267,
447-454[Abstract/Free Full Text]
|
| 42.
|
Arai, H.,
Berne, M.,
Terres, G.,
Terres, H.,
Puopolo, K.,
and Forgac, M.
(1987)
Biochemistry
26,
6632-6638[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Dschida, W. J.,
and Bowman, B. J.
(1995)
J. Biol. Chem.
270,
1557-1563[Abstract/Free Full Text]
|
| 44.
|
Futai, M.,
Noumi, T.,
and Maeda, M.
(1989)
Annu. Rev. Biochem.
58,
111-136[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Leng, X. H.,
Manolson, M. F.,
and Forgac, M.
(1998)
J. Biol. Chem.
273,
6717-6723[Abstract/Free Full Text]
|
| 46.
|
Noji, H.,
Yasuda, R.,
Yoshida, M.,
and Kinosita, K., Jr.
(1997)
Nature
386,
299-302[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Sabbert, D.,
Engelbrecht, S.,
and Junge, W.
(1996)
Nature
|